HomeBusinessHealthcare Industry Stock NewsEli Lilly (LLY) Hits Highs After FDA Approves Its Alzheimer’s Treatment

Eli Lilly (LLY) Hits Highs After FDA Approves Its Alzheimer’s Treatment

Eli Lilly (LLY) hit a new all-time high today as the FDA approved its Alzheimer’s treatment “Kisunla.” The treatment is intended for adults in early symptomatic stages of Alzheimer’s disease.

Morning Trade Live

03 Jul 2024

SHARE

ON AIR
education
10:00 pm
Inside the Mind of a Trader
replay
12:00 am
Trading 360
REPLAY
1:00 am
Fast Market
REPLAY
2:00 am
Next Gen Investing
REPLAY
3:00 am
Market Overtime
REPLAY
3:30 am
Market Overtime
REPLAY
education
4:00 am
Your First Trade
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Inside the Mind of a Trader
REPLAY
6:00 am
Market Overtime
REPLAY
6:30 am
Market Overtime
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Trading 360
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
ON AIR
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor